title: Postoperative radiotherapy in periampullary cancers: a brief review.
abstract: BACKGROUND
  The treatment of periampullary cancers is complex and challenging. Adjuvant therapy for resected periampullary and pancreatic cancers has been the subject of intense clinical investigations for several decades. Periampullary cancer management has often been clubbed with pancreatic cancers.
  
  
  CONCLUSIONS
  Following surgery, adjuvant chemoradiotherapy has been widely accepted as standard of care in the USA, although different prospective and retrospective studies have shown conflicting results. Controversy regarding the effectiveness of chemoradiotherapy exists in the literature, both in terms of survival as well as toxicity. However, conventional postoperative radiotherapy practice needs to be reviewed in view of changes and developments in radiation techniques in the last decade. In this article, we review the management of periampullary cancers with special emphasis on the adjuvant postoperative radiotherapy.
authors: Department of Radiation Oncology, Post-Graduate Institute of Medical Education and Research (PGIMER), Chandigarh, 160012, India. dramitbahl@yahoo.com
authors: Amit
authors: A
authors: Bahl
authors: Tapesh
authors: T
authors: Bhattacharyya
authors: Rakesh
authors: R
authors: Kapoor
authors: Oinam A
authors: OA
authors: Singh
authors: Tomar
authors: T
authors: Parsee
authors: Suresh C
authors: SC
authors: Sharma
mesh_terms: D014670:Ampulla of Vater / Q000528:radiation effects*; D003138:Common Bile Duct Neoplasms / Q000532:radiotherapy*; D006801:Humans; D011379:Prognosis